Physician profile
Katrina E Grablin
NPI 1093938250
$751.25
in general payments reported to CMS, 2019-2025
16 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $34.17 · 2023: $259 · 2024: $165 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $270.95 | 2023-2025 | Puraply, Cygnus Dual, Novachor |
| Becton, Dickinson and Company | $146.50 | 2024 | Phasix Mesh |
| Regeneron Healthcare Solutions, INC. | $47.34 | 2023 | Libtayo |
| Paratek Pharmaceuticals, INC. | $40.27 | 2021 | |
| Trevena, INC. | $37.35 | 2023 | Olinvyk |
| Smith+Nephew, INC. | $32.93 | 2023 | Collagenase Santyl, Regranex |
| Biohaven Pharmaceuticals, INC. | $23.59 | 2021 | |
| Esperion Therapeutics, INC. | $23.42 | 2021 | |
| Hologic Sales and Service, LLC | $19.81 | 2022 | |
| Ironshore Pharmaceuticals INC. | $19.36 | 2021 | |
| Eisai INC. | $18.13 | 2021 | |
| Alexion Pharmaceuticals, INC. | $17.15 | 2021 | |
| Medtronic, INC. | $14.36 | 2022 | |
| Novo Nordisk INC | $14.17 | 2021 | |
| Lilly USA, LLC | $13.86 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Grablin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.